Theradiag
4 Bd de Beaubourg – Actipole 25 – Croissy Beaubour
Marne La Vallee cedex 2
77435
France
Tel: 01-64-62-10-12
Fax: 01-64-62-09-66
Website: http://www.theradiag.com/
Email: info@theradiag.com
46 articles about Theradiag
-
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
6/8/2022
Quotient Limited announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform.
-
BioSpace Movers and Shakers: Dec. 17
12/17/2018
With the year closing out, biotech and pharma companies are making adjustments to their leadership ranks and boards of directors. -
THERADIAG Signs a Partnership Agreement for Monitoring of Remicade
12/22/2017
Theradiag today announced that it had signed a partnership with MSD France to supply its LISA TRACKER kits for the monitoring of Remicade.
-
THERADIAG Provides an Update on Prestizia and its Partnership With HOB Biotech
12/20/2017
Theradiag today announced the discontinuation of its Prestizia research activity, a wholly-owned subsidiary of Theradiag, and provides an update on contracts renegotiation discussions with HOB Biotech.
-
Theradiag Release: Revenues at the End of September 30, 2017
10/30/2017
During the period to September 30, 2017, Theradiag generated consolidated revenues of €6.8 million, up +7% compared with 2016.
-
Theradiag Release: Free Allocation Of Redeemable Stock Warrants For The Benefit Of Shareholders Of The Company
6/15/2017
-
Theradiag Release: First-Quarter 2017 Revenues
4/27/2017
-
Sixth Test In Theradiag's Monitoring Range Launched In The U.S.A.
3/28/2017
-
Theradiag Release: Full-Year 2016 Results
3/1/2017
-
Theradiag Receives Support For Its Development Of microRNA Biomarkers In Oncology From The Eurostars-Eureka Program
1/26/2017
-
Theradiag Release: LISA TRACKER Launched In The U.S. Market
6/16/2016
-
Theradiag Release: First-Quarter 2016 Revenues Up 50%
4/25/2016
-
Theradiag Expands Its Biotherapy Monitoring Range, With A New CE Marking Obtained For Its Entyvio Test
12/14/2015
-
Theradiag Release: Results Of The Roc Trial Demonstrate The Benefits Of Monitoring Biotherapies
12/8/2015
-
Theradiag Announces Strategic Agreement With Miraca Life Sciences In The U.S.A.
11/18/2015
-
Theradiag Signs Collaboration Agreements With Unicancer And Bordeaux University Hospital To Advance Micro RNA Project
7/22/2015
-
Theradiag Release: New Study Shows Predictive Role Of Theranostics In Inflammatory Bowel Disease
6/17/2015
-
Theradiag Receives Frost & Sullivan 2015 European Theranostics Product Leadership Award
5/26/2015
-
Theradiag And Hospira Sign A Partnership Agreement
5/20/2015
-
Theradiag Launches Lisa Tracker In Canada
5/11/2015